Phacolytic glaucoma the lens to become cloudy and gradually turn opaque, causing a decrease in vision. Through the leakage of proteins that have a high molecular weight an obstruction of the drainage mechanism of the eye is caused. A variety of procedures can be used to physically diagnose phacolytic glaucoma as there are a variety of other types of glaucoma which may be confused with phacolysis such as acute angle-closure glaucoma (AACG), lens-particle glaucoma, neovascular glaucoma, phacomorphic glaucoma and uveitic glaucoma which can cause confusion in which procedures need to be conducted to revamp vision. The first type of diagnosis procedure referred
Glaucoma known as anti-VEGF agents. These injectable medications can lead to a dramatic decrease in new vessel formation and, if injected early enough in the disease process, may lead to normalization of intraocular pressure. Currently, there are no high-quality controlled trials demonstrating a beneficial effect of anti-VEGF treatments in lowering IOP in people with neovascular glaucoma. Toxic glaucoma is open-angle glaucoma with an unexplained significant rise of intraocular pressure following unknown pathogenesis. Intraocular pressure can sometimes reach . It characteristically manifests as ciliary body inflammation and massive trabecular oedema that sometimes extends to Schlemm's canal. This condition is differentiated from malignant